PMID |
Dilution |
Publication |
38973508 | not listed | Squarcio, F., et al. 2024. Effects of non-rapid eye movement sleep on the cortical synaptic expression of GluA1-containing AMPA receptors. The European Journal of Neuroscience, 3961-3972. |
37174668 | 1:100 | Hassan, Z, et al. 2023. Cognitive Impairment Is Associated with AMPAR Glutamatergic Dysfunction in a Mouse Model of Neuronal Methionine Synthase Deficiency. Cells, 1267. |
36565803 | not listed | Mao, L.M., et al. 2022. An Allosteric Potentiator of Metabotropic Glutamate (mGlu) 2 Receptors Reduces the Cocaine-Stimulated ERK1/2 Phosphorylation in the Mouse Striatum. Neuroscience Netters, 137028. |
36565803 | not listed | Mao, L.M., et al. 2022. An Allosteric Potentiator of Metabotropic Glutamate (mGlu) 2 Receptors Reduces the Cocaine-Stimulated ERK1/2 Phosphorylation in the Mouse Striatum. Neuroscience Netters, 137028. |
36446153 | not listed | Wei, W., et al. 2022. The Mevalonate Suppressor δ-Tocotrienol Increases AMPA Receptor-Mediated Neurotransmission. Biochemical And Biophysical Research Communications, 112-119. |
36351540 | 1:250 | Kuroiwa, M., et al. 2022. DARPP-32/protein phosphatase 1 regulates Rasgrp2 as a novel component of dopamine D1 receptor signaling in striatum. Neurochemistry International, 105438. |
34131032 |
1:250 |
Sugiyama, K., et al. 2021. Subregion-Specific Regulation of Dopamine D1 Receptor Signaling in the Striatum: Implication for L-DOPA-Induced Dyskinesia. Journal of Neuroscience, 40(31), 6388-6414. |
33853773 |
1:1000 |
Cook, S.G., et al. 2021. CaMKII holoenzyme mechanisms that govern the LTP versus LTD decision. Science Advances, 7(16), p.eabe2300. |
30831136 |
1:250 |
Hikida, T., et al. 2019. Adolescent psychosocial stress enhances sensitization to cocaine exposure in genetically vulnerable mice. Neuroscience Research, pii: S0168-0102(19)30021-5. |
28613156 |
1:1000 |
Musante, V., et al. 2017. Reciprocal regulation of ARPP-16 by PKA and MAST3 kinases provides a cAMP-regulated switch in protein phosphatase 2A inhibition. Elife, 6, p.e24998. |
28167675 |
1:1000 |
Andrade, E.C., et al. 2017. ARPP-16 is a striatal-enriched inhibitor of protein phosphatase 2A regulated by microtubule-associated serine/threonine kinase 3 (Mast 3 kinase). Journal of Neuroscience, pp.4559-15. |
25971971 |
not listed |
Tassin, T.C., et al. 2015. Regulation of ERK Kinase by MEK1 Kinase Inhibition in the Brain. Journal of Biological Chemistry, Jun 26;290(26):16319-29. |
25649278 |
not listed |
Ip, F.C., et al. 2015. Anemoside A3 Enhances Cognition through the Regulation of Synaptic Function and Neuroprotection. Neuropsychopharmacology, 40, 1877–1887. |
25525190 |
not listed |
Suzuki, K., et al. 2015. In Vivo Pharmacological Characterization of TAK-063, a Potent and Selective Phosphodiesterase 10A Inhibitor with Antipsychotic-Like Activity in Rodents. Journal of Pharmacology and Experimental Therapeutics, 352:471-479. |
25173217 |
1:1000 |
Mango, D., et al. 2014. Adenosine A1 receptor stimulation reduces D1 receptor-mediated GABAergic transmission from striato-nigral terminals and attenuates l-DOPA-induced dyskinesia in dopamine-denervated mice. Experimental Neurology, 261, pp.733-743. |
25136890 |
1:1000 |
Squillace, M., et al. 2014. Dysfunctional dopaminergic neurotransmission in asocial BTBR mice. Translational Psychiatry, 4(8), p.e427. |
25115542 |
not listed |
Wang, J., et al. 2014. Fluoxetine Improves Behavioral Performance by Suppressing the Production of Soluble β-Amyloid in APP/PS1 Mice. Current Alzheimer Research, 11(7), 672-680. |
24920629 |
not listed |
Meyer, D.A., et al. 2014. Ischemic stroke injury is mediated by aberrant Cdk5. The Journal of Neuroscience, 34(24), 8259-8267. |
24907515 |
not listed |
Mao, L.M., et al. 2014. Propofol selectively alters GluA1 AMPA receptor phosphorylation in the hippocampus but not prefrontal cortex in young and aged mice. European Journal of Pharmacology, 738, 237-244. |
23303927 |
not listed |
Shen, Y., et al. 2013. Melanocortin-4 receptor regulates hippocampal synaptic plasticity through a protein kinase A-dependent mechanism. Journal of Neuroscience 33(2):464-72. |
22753408 |
1:1000 |
Santini, E., et al. 2012. Dopamine- and cAMP-regulated phosphoprotein of 32-kDa (DARPP-32)-dependent activation of extracellular signal-regulated kinase (ERK) and mammalian target of rapamycin complex 1 (mTORC1) signaling in experimental parkinsonism. Journal of Biological Chemistry 287(33):27806-12. |
21946266 |
not listed |
Errico, F., et al. 2011. Higher free D-aspartate and N-methyl-D-aspartate levels prevent striatal depotentiation and anticipate L-DOPA-induced dyskinesia. Experimental Neurology, 232(2), pp.240-250. |
20720111 |
1:1000 |
Napolitano, F., et al. 2010. Role of aberrant striatal dopamine D1 receptor/cAMP/protein kinase A/DARPP32 signaling in the paradoxical calming effect of amphetamine. Journal of Neuroscience, 30(33), pp.11043-11056. |
20554878 |
1:500 |
Sears, R.M., et al. 2010. Regulation of Nucleus Accumbens Activity by the Hypothalamic Neuropeptide Melanin-Concentrating Hormone. Journal of Neuroscience, 30: 8263-8273. |
19666609 |
not listed |
Rebholz, H., et al. 2009. CK2 negatively regulates G s signaling. PNAS, 106: 14096-14101. |
19622833 |
1:750 |
Santini, E., et al. 2009. Inhibition of mTOR Signaling in Parkinson’s Disease Prevents L-DOPA–Induced Dyskinesia. Science Singalling, Jul 2009; 2: ra36. |
19017804 |
not listed |
Meyer, D.A., et al. 2008. Striatal dysregulation of Cdk5 alters locomotor responses to cocaine, motor learning, and dendritic morphology. PNAS, 105: 18561 - 18566. |
18923023 |
1:250 |
Nishi, A., et al. 2008. Distinct Roles of PDE4 and PDE10A in the Regulation of cAMP/PKA Signaling in the Striatum. Journal of Neuroscience, 28: 10460– 10471. |
18417701 |
1:500 |
Sun, X., et al. 2008. Acute and chronic dopamine receptor stimulation modulates AMPA receptor trafficking in nucleus accumbens neurons cocultured with prefrontal cortex neurons. Journal of Neuroscience Apr 16;28(16):4216-30. |
17923095 |
not listed |
Hu,H., et al. 2007. Emotion enhances learning via norepinephrine regulation of AMPA-receptor trafficking. Cell, 131(1), pp.160-173. |